Despite the importance of blood ASM as a biomarker, most studies on neurological disorder pathogenesis have focused on CNS tissues, and the effects on the peripheral nervous system regarding disease onset and progression have not been fully elucidated. The gene discussed is SMPD1; the disease is nervous system disorder.